Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZZ) Assets (2020 - 2025)

Historic Assets for Core Scientific (CORZZ) over the last 6 years, with Q3 2025 value amounting to $2.3 billion.

  • Core Scientific's Assets rose 14906.19% to $2.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 14906.19%. This contributed to the annual value of $1.6 billion for FY2024, which is 12450.35% up from last year.
  • Per Core Scientific's latest filing, its Assets stood at $2.3 billion for Q3 2025, which was up 14906.19% from $2.0 billion recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's Assets peaked at $2.7 billion during Q1 2022, and registered a low of $347.1 million during Q3 2021.
  • Moreover, its 5-year median value for Assets was $814.0 million (2024), whereas its average is $1.2 billion.
  • As far as peak fluctuations go, Core Scientific's Assets surged by 1625899333.33% in 2021, and later plummeted by 7189.33% in 2023.
  • Core Scientific's Assets (Quarter) stood at $2.4 billion in 2021, then tumbled by 66.88% to $807.7 million in 2022, then fell by 11.83% to $712.2 million in 2023, then soared by 124.5% to $1.6 billion in 2024, then skyrocketed by 43.61% to $2.3 billion in 2025.
  • Its last three reported values are $2.3 billion in Q3 2025, $2.0 billion for Q2 2025, and $1.6 billion during Q1 2025.